Place of apremilast in the real-life treatment of patients with plaque psoriasis

被引：0

作者：

Gisondi, P. ^{[1
]}

Geat, D. ^{[1
]}

Girolomoni, G. ^{[1
]}

机构：

[1] Univ Verona, Sect Dermatol & Venereol, Dept Med, Verona, Italy

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2021年 / 35卷 / 01期

关键词：

PHASE-III; MODERATE; INHIBITOR; EFFICACY; SAFETY;

D O I：

10.1111/jdv.17067

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：13 / 13

页数：1

共 6 条

[1] Pathophysiology, Clinical Presentation, and Treatment of Psoriasis A Review [J].

Armstrong, April W. ;

Read, Charlotte .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (19) :1945-1960

[2] Characteristics and outcomes of patients treated with apremilast in the real world: results from the APPRECIATE study [J].

Augustin, M. ;

Kleyn, C. E. ;

Conrad, C. ;

Sator, P. G. ;

Stahle, M. ;

Eyerich, K. ;

Radtke, M. A. ;

Bundy, C. ;

Mellars, L. ;

Greggio, C. ;

Cordey, M. ;

Koscielny, V ;

Griffiths, C. E. M. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (01) :123-134

[3] Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis [J].

Gisondi, P. ;

Altomare, G. ;

Ayala, F. ;

Bardazzi, F. ;

Bianchi, L. ;

Chiricozzi, A. ;

Costanzo, A. ;

Conti, A. ;

Dapavo, P. ;

De Simone, C. ;

Foti, C. ;

Naldi, L. ;

Offidani, A. ;

Parodi, A. ;

Piaserico, S. ;

Prignano, F. ;

Rongioletti, F. ;

Stingeni, L. ;

Talamonti, M. ;

Girolomoni, G. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (05) :774-790

[4] Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1) [J].

Papp, Kim ;

Reich, Kristian ;

Leonardi, Craig L. ;

Kircik, Leon ;

Chimenti, Sergio ;

Langley, Richard G. B. ;

Hu, ChiaChi ;

Stevens, Randall M. ;

Day, Robert M. ;

Gordon, Kenneth B. ;

Korman, Neil J. ;

Griffiths, Christopher E. M. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (01) :37-49

[5] Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2) [J].

Paul, C. ;

Cather, J. ;

Gooderham, M. ;

Poulin, Y. ;

Mrowietz, U. ;

Ferrandiz, C. ;

Crowley, J. ;

Hu, C. ;

Stevens, R. M. ;

Shah, K. ;

Day, R. M. ;

Girolomoni, G. ;

Gottlieb, A. B. .

BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (06) :1387-1399

[6] Psychodermatological mechanisms of psoriasis [J].

Torales, Julio ;

Echeverria, Cristina ;

Barrios, Ivan ;

Garcia, Oscar ;

O'Higgins, Marcelo ;

Castaldelli-Maia, Joao Mauricio ;

Ventriglio, Antonio ;

Jafferany, Mohammad .

DERMATOLOGIC THERAPY, 2020, 33 (06)

← 1 →